Concepedia

Magali de Sauvage

MD

Statistics

Publications

6

Citations

565

H-Index

6

Active since

2020

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Broad Institute

Magali de Sauvage is an author at Massachusetts General Hospital specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2020–2023

6

Publications

6

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

David Shih, Naema Nayyar, Ivanna V. Bihun et al. · Nature Genetics · 2020 · 302 citations · Full text

, , +16

Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas

Priscilla K. Brastianos, Albert E. Kim, Anita Giobbie‐Hurder et al. · Nature Communications · 2022 · 112 citations · Full text

, , +17

Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results

Priscilla K. Brastianos, Albert E. Kim, Anita Giobbie‐Hurder et al. · Nature Medicine · 2023 · 65 citations · Full text

, , +15

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Christopher Alvarez‐Breckenridge, Samuel C. Markson, Jackson H. Stocking et al. · Cancer Immunology Research · 2022 · 53 citations · Full text

, , +17

CDK4/6 Inhibition Sensitizes Intracranial Tumors to PD-1 Blockade in Preclinical Models of Brain Metastasis

Naema Nayyar, Magali de Sauvage, Jane Chuprin et al. · Clinical Cancer Research · 2023 · 23 citations · Full text

, , +17

1–5 of 6